Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Trxade Health Inc (MEDS)

Trxade Health Inc (MEDS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,870
  • Shares Outstanding, K 9,319
  • Annual Sales, $ 9,890 K
  • Annual Income, $ -5,320 K
  • 60-Month Beta 1.16
  • Price/Sales 0.57
  • Price/Cash Flow N/A
  • Price/Book 3.62
Trade MEDS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.40
  • Most Recent Earnings -0.06 on 11/07/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5111 +23.24%
on 11/22/22
0.9110 -30.86%
on 10/31/22
-0.2576 (-29.03%)
since 10/25/22
3-Month
0.5111 +23.24%
on 11/22/22
1.5200 -58.56%
on 09/08/22
-0.4502 (-41.68%)
since 08/25/22
52-Week
0.5111 +23.24%
on 11/22/22
3.7264 -83.10%
on 11/26/21
-2.8401 (-81.85%)
since 11/24/21

Most Recent Stories

More News
TRxADE (MEDS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

TRxADE (MEDS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend...

MEDS : 0.6299 (+5.02%)
All You Need to Know About TRxADE (MEDS) Rating Upgrade to Buy

TRxADE (MEDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MEDS : 0.6299 (+5.02%)
TRxADE (MEDS) Reports Q3 Loss, Lags Revenue Estimates

TRxADE (MEDS) delivered earnings and revenue surprises of 50% and 27.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MEDS : 0.6299 (+5.02%)
GDRX : 4.69 (-1.68%)
1 Drugstore Stock to Buy Right Now and 2 to Sell

An ageing population and rising healthcare expenditure due to increased awareness among the masses are expected to boost demand for drugstore products. On the other hand, the stock market is experiencing...

CVS : 101.26 (+1.20%)
MEDS : 0.6299 (+5.02%)
RAD : 5.43 (+2.84%)
TRxADE Health (NASDAQ: MEDS) Subsidiary, Bonum Health Enters into Telehealth Services Deal with Wakefern Food Corp.

TRxADE Health, Inc. (NASDAQ: MEDS) is engaged as a health services IT company, which is focused on digitalizing the entire

AAPL : 148.11 (-1.96%)
MEDS : 0.6299 (+5.02%)
TRxADE (MEDS) Reports Q2 Loss, Tops Revenue Estimates

TRxADE (MEDS) delivered earnings and revenue surprises of -44.44% and 13.07%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MEDS : 0.6299 (+5.02%)
SKIN : 9.93 (-1.59%)
TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform

MEDS : 0.6299 (+5.02%)
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC

TAMPA, FL / ACCESSWIRE / July 12, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Integra Pharma...

MEDS : 0.6299 (+5.02%)
TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m. Eastern Time

TAMPA, FL / ACCESSWIRE / July 11, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription...

MEDS : 0.6299 (+5.02%)
Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services

TAMPA, FL / ACCESSWIRE / May 19, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business...

MEDS : 0.6299 (+5.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TRxADE HEALTH INC. is a health services IT company focused on digitalizing the retail pharmacy experience. TRxADE HEALTH INC., formerly known as TRxADE Group Inc., is based in TAMPA, FL.

See More

Key Turning Points

3rd Resistance Point 0.6703
2nd Resistance Point 0.6502
1st Resistance Point 0.6401
Last Price 0.6299
1st Support Level 0.6099
2nd Support Level 0.5898
3rd Support Level 0.5797

See More

52-Week High 3.7264
Fibonacci 61.8% 2.4982
Fibonacci 50% 2.1187
Fibonacci 38.2% 1.7393
Last Price 0.6299
52-Week Low 0.5111

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar